424 related articles for article (PubMed ID: 23876536)
1. Serum antimüllerian hormone in response to dietary management and/or physical exercise in overweight/obese women with polycystic ovary syndrome: secondary analysis of a randomized controlled trial.
Nybacka Å; Carlström K; Fabri F; Hellström PM; Hirschberg AL
Fertil Steril; 2013 Oct; 100(4):1096-102. PubMed ID: 23876536
[TBL] [Abstract][Full Text] [Related]
2. Diet, physical exercise and Orlistat administration increase serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS).
Vosnakis C; Georgopoulos NA; Rousso D; Mavromatidis G; Katsikis I; Roupas ND; Mamali I; Panidis D
Gynecol Endocrinol; 2013 Mar; 29(3):242-5. PubMed ID: 23194076
[TBL] [Abstract][Full Text] [Related]
3. Randomized comparison of the influence of dietary management and/or physical exercise on ovarian function and metabolic parameters in overweight women with polycystic ovary syndrome.
Nybacka Å; Carlström K; Ståhle A; Nyrén S; Hellström PM; Hirschberg AL
Fertil Steril; 2011 Dec; 96(6):1508-13. PubMed ID: 21962963
[TBL] [Abstract][Full Text] [Related]
4. The effect of weight loss on anti-Müllerian hormone levels in overweight and obese women with polycystic ovary syndrome and reproductive impairment.
Thomson RL; Buckley JD; Moran LJ; Noakes M; Clifton PM; Norman RJ; Brinkworth GD
Hum Reprod; 2009 Aug; 24(8):1976-81. PubMed ID: 19380385
[TBL] [Abstract][Full Text] [Related]
5. Serum anti-Müllerian hormone and ovarian morphology assessed by magnetic resonance imaging in response to acupuncture and exercise in women with polycystic ovary syndrome: secondary analyses of a randomized controlled trial.
Leonhardt H; Hellström M; Gull B; Lind AK; Nilsson L; Janson PO; Stener-Victorin E
Acta Obstet Gynecol Scand; 2015 Mar; 94(3):279-87. PubMed ID: 25545309
[TBL] [Abstract][Full Text] [Related]
6. Sibutramine administration decreases serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome.
Vosnakis C; Georgopoulos NA; Armeni AK; Papadakis E; Roupas ND; Katsikis I; Panidis D
Eur J Obstet Gynecol Reprod Biol; 2012 Aug; 163(2):185-9. PubMed ID: 22579228
[TBL] [Abstract][Full Text] [Related]
7. Exercise decreases anti-müllerian hormone in anovulatory overweight women with polycystic ovary syndrome: a pilot study.
Moran LJ; Harrison CL; Hutchison SK; Stepto NK; Strauss BJ; Teede HJ
Horm Metab Res; 2011 Dec; 43(13):977-9. PubMed ID: 21989557
[TBL] [Abstract][Full Text] [Related]
8. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
Graff SK; Mário FM; Alves BC; Spritzer PM
Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
[TBL] [Abstract][Full Text] [Related]
9. Age-specific serum antimüllerian hormone levels in women with and without polycystic ovary syndrome.
Cui Y; Shi Y; Cui L; Han T; Gao X; Chen ZJ
Fertil Steril; 2014 Jul; 102(1):230-236.e2. PubMed ID: 24746743
[TBL] [Abstract][Full Text] [Related]
10. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
[TBL] [Abstract][Full Text] [Related]
11. The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome.
Thomson RL; Buckley JD; Noakes M; Clifton PM; Norman RJ; Brinkworth GD
J Clin Endocrinol Metab; 2008 Sep; 93(9):3373-80. PubMed ID: 18583464
[TBL] [Abstract][Full Text] [Related]
12. The effect of weight loss program on serum anti-Müllerian hormone level in obese and overweight infertile women with polycystic ovary syndrome.
Moini A; Arabipoor A; Hemat M; Ahmadi J; Salman-Yazdi R; Zolfaghari Z
Gynecol Endocrinol; 2019 Feb; 35(2):119-123. PubMed ID: 30580636
[TBL] [Abstract][Full Text] [Related]
13. Androgens and antimüllerian hormone in mothers with polycystic ovary syndrome and their newborns.
Vanky E; Carlsen SM
Fertil Steril; 2012 Feb; 97(2):509-15. PubMed ID: 22154766
[TBL] [Abstract][Full Text] [Related]
14. Parallel variations of insulin-like peptide 3 (INSL3) and antimüllerian hormone (AMH) in women with the polycystic ovary syndrome according to menstrual cycle pattern.
Pelusi C; Fanelli F; Pariali M; Zanotti L; Gambineri A; Pasquali R
J Clin Endocrinol Metab; 2013 Oct; 98(10):E1575-82. PubMed ID: 23928669
[TBL] [Abstract][Full Text] [Related]
15. Impact of electro-acupuncture and physical exercise on hyperandrogenism and oligo/amenorrhea in women with polycystic ovary syndrome: a randomized controlled trial.
Jedel E; Labrie F; Odén A; Holm G; Nilsson L; Janson PO; Lind AK; Ohlsson C; Stener-Victorin E
Am J Physiol Endocrinol Metab; 2011 Jan; 300(1):E37-45. PubMed ID: 20943753
[TBL] [Abstract][Full Text] [Related]
16. The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndrome.
Romualdi D; De Cicco S; Tagliaferri V; Proto C; Lanzone A; Guido M
J Clin Endocrinol Metab; 2011 May; 96(5):E821-4. PubMed ID: 21307134
[TBL] [Abstract][Full Text] [Related]
17. Antimüllerian hormone levels and cardiometabolic risk in young women with polycystic ovary syndrome.
Feldman RA; O'Neill K; Butts SF; Dokras A
Fertil Steril; 2017 Jan; 107(1):276-281. PubMed ID: 27842995
[TBL] [Abstract][Full Text] [Related]
18. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
[TBL] [Abstract][Full Text] [Related]
19. The use of anti-mullerian hormone in predicting menstrual response after weight loss in overweight women with polycystic ovary syndrome.
Moran LJ; Noakes M; Clifton PM; Norman RJ
J Clin Endocrinol Metab; 2007 Oct; 92(10):3796-802. PubMed ID: 17652213
[TBL] [Abstract][Full Text] [Related]
20. Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?
Skałba P; Cygal A; Madej P; Dąbkowska-Huć A; Sikora J; Martirosian G; Romanik M; Olszanecka-Glinianowicz M
Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):254-9. PubMed ID: 21752527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]